Vaxcyte, Inc. Share Price
NASDAQ: PCVX | Mid CapVaxcyte, Inc. Stock Performance
Vaxcyte, Inc. Share Price Today
As of 8 October 2026, Vaxcyte, Inc.'s share price is $66.58. The stock opened at $67.24, compared to its previous close of $66.79. During today's trading session, Vaxcyte, Inc.'s share price traded between $66.49 and $67.67, with an average price of $67.08. Over the past 52 weeks, the stock has recorded a high of $90.08 and a low of $39.91. In terms of performance, Vaxcyte, Inc.'s share price has risen by 16.24% over the last six months and is up 47.06% on a year-on-year basis.
Vaxcyte, Inc. Share Price Chart
Vaxcyte, Inc. Quarterly Profit & Loss
All figures in USD
Vaxcyte, Inc. Annual Profit & Loss
All figures in USD
About Vaxcyte, Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Vaxcyte, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $56.89 | $67.36 | +18.18% |
Sep 2026 | $60.85 | $57.00 | -6.73% |
Aug 2026 | $54.01 | $61.12 | +13.03% |
Jul 2026 | $58.02 | $54.07 | -6.94% |
Jun 2026 | $50.45 | $58.10 | +12.98% |
May 2026 | $56.91 | $51.42 | -10.22% |
Apr 2026 | $58.69 | $57.28 | -1.34% |
Mar 2026 | $60.14 | $58.06 | -5.93% |
Feb 2026 | $53.59 | $61.72 | +15.11% |
Jan 2026 | $46.31 | $53.62 | +16.31% |
Dec 2025 | $44.98 | $46.10 | -6.84% |
Nov 2025 | $45.13 | $49.48 | +9.30% |